AI-Squared Management’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History
Bought
Maintained
Sold
Other funds holding LABD
VF
HF
TSS
GS
QC
TRCT
AI-Squared Management's LABD Position: Q2 2024 in Review
AI-Squared Management sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2024, closing a stake of 18,975 shares — an estimated $1.38M sold.
AI-Squared Management first reported a position in LABD in Q1 2024 and held it in 1 quarter. The position peaked at $1.38M in Q1 2024. 17 funds tracked by Wall St. Rank hold LABD as of Q2 2024.
- AI-Squared Management reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q2 2024 after selling out during the quarter.
- AI-Squared Management sold 18,975 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2024, an estimated $1.38M.
- AI-Squared Management first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2024 and held it in 1 quarter.
- AI-Squared Management's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $1.38M in Q1 2024.
- 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2024.
Based on AI-Squared Management's 13F filing for Q2 2024, filed 9 Aug 2024.